These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7792816)

  • 21. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
    Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
    J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):99-103. PubMed ID: 6292258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent hypercortisolism and hypermineralocorticoidism.
    Hogan MJ; Schambelan M; Biglieri EG
    Am J Med; 1977 May; 62(5):777-82. PubMed ID: 871129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renin-angiotensin-(aldosterone)-system-clinical aspects].
    Börner H
    Z Gesamte Inn Med; 1973 Dec; 28(24):757-62. PubMed ID: 4360460
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency.
    Kater CE; Biglieri EG; Wajchenberg B
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1057-62. PubMed ID: 2987285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural history of salt-wasting disorders of adrenal and renal origin.
    Rösler A
    J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New mineralocorticoids and adrenocorticosteroids in hypertension.
    Melby JC; Dale SL
    Am J Cardiol; 1976 Nov; 38(6):805-13. PubMed ID: 136892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary aldosteronism.
    Gordon RD
    J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
    Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
    Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deoxycorticosterone, 11 beta-hydroxylase and the adrenal cortex.
    Spoudeas HA; Slater JD; Rumsby G; Honour JW; Brook CG
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):245-51. PubMed ID: 8370138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical response to metyrapone as indicated by measurement of mineralocorticoids and glucocorticoids in normal children.
    Sonino N; Chow D; Levine LS; New MI
    Clin Endocrinol (Oxf); 1981 Jan; 14(1):31-9. PubMed ID: 7226574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues.
    Sharma KK; Lindqvist A; Zhou XJ; Auchus RJ; Penning TM; Andersson S
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):79-86. PubMed ID: 16337083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
    Guthrie GP
    J Lab Clin Med; 1981 Sep; 98(3):364-73. PubMed ID: 6267148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineralocorticoid hypertension due to hyperaldosteronism and hyperdeoxycorticosteronism.
    Biglieri EG; Kater CE; Arteaga EA
    J Hypertens Suppl; 1986 Dec; 4(5):S61-5. PubMed ID: 3553487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE; Montero J; Mosso L
    Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zona glomerulosa function after life-long suppression in two siblings with the hypertensive virilizing form of congenital adrenal hyperplasia.
    Rodríguez Portales JA; Arteaga E; López Moreno JM; Biglieri EG
    J Clin Endocrinol Metab; 1988 Feb; 66(2):349-54. PubMed ID: 3276723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unconjugated and conjugated urinary 19-nor-deoxycorticosterone glucosiduronate. Elevated levels in essential hypertension.
    Griffing GT; Wilson TE; Melby JC
    Hypertension; 1985; 7(3 Pt 2):I12-7. PubMed ID: 3873413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous determination of plasma 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone, and aldosterone in man.
    Ojima M; Aida M; Kambegawa A
    Tohoku J Exp Med; 1978 Apr; 124(4):367-79. PubMed ID: 663934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenal cortex, tumor, and peripheral production of deoxycorticosterone.
    Schneider MA; Honour JW
    Steroids; 1992 Jan; 57(1):7-12. PubMed ID: 1316648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.